亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。
Mithramycin analogues and their application against Ewing sarcoma - 2004
技術優勢
Aberrantregulation of FLI1 as well as other transcription factors (eg ERG) areimplicated in several cancers and often result in malignant transformations. Acharacteristic of Ewing Sarcoma involves a chromosomal translocation resultingin a chimeric EWS-FLI1 fusion protein. Mithramycin has been identified as apotent inhibitor of EWS-FLI1, but has also proved to be highly toxic tonon-sarcoma cells. To address this, Rohr and colleagues have created MTManalogues to improve the performance, selectivity, and efficacy of MTM.
詳細技術說明
None
國家/地區
美國
欲了解更多信息，請點擊 這裡
